Wed, May 15, 8:16 PM (244 days ago)
Zura Bio Limited filed an amendment (Form 10-Q/A) for Q1 2024, solely to correct the number of outstanding Class A ordinary shares reported. As of May 9, 2024, the company had 63,683,806 Class A Ordinary Shares and 12,809,996 Public Warrants outstanding. The amendment does not introduce any other changes to the original Form 10-Q. The report confirms compliance with SEC filing requirements and includes certifications from the Principal Executive and Financial Officers. There are no significant legal proceedings, unregistered sales of equity securities, defaults on senior securities, or mine safety disclosures. The amendment includes various exhibits, such as employment agreements and certifications pursuant to the Sarbanes-Oxley Act. This correction ensures accurate reporting of the company's share structure, which is crucial for investors and regulatory compliance.